COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants.

Junker, Daniel; Dulovic, Alex; Becker, Matthias; Wagner, Teresa R; Kaiser, Philipp D; Traenkle, Bjoern; Kienzle, Katharina; Bunk, Stefanie; Struemper, Carlotta; Haeberle, Helene; Schmauder, Kristina; Ruetalo, Natalia; Malek, Nisar; Althaus, Karina; Koeppen, Michael; Rothbauer, Ulrich; Walz, Juliane S; Schindler, Michael; Bitzer, Michael; Göpel, Siri; Schneiderhan-Marra, Nicole

Junker, Daniel; Dulovic, Alex; Becker, Matthias; Wagner, Teresa R; Kaiser, Philipp D; Traenkle, Bjoern; Kienzle, Katharina; Bunk, Stefanie; Struemper, Carlotta; Haeberle, Helene; Schmauder, Kristina; Ruetalo, Natalia; Malek, Nisar; Althaus, Karina; Koeppen, Michael; Rothbauer, Ulrich; Walz, Juliane S; Schindler, Michael; Bitzer, Michael; Göpel, Siri; Schneiderhan-Marra, Nicole.

Affiliation

Junker D; NMI Natural and Medical Sciences Institute at the University of Tübingen, Markwiesenstrasse 55, 72770, Reutlingen, Germany.
Dulovic A; NMI Natural and Medical Sciences Institute at the University of Tübingen, Markwiesenstrasse 55, 72770, Reutlingen, Germany.
Becker M; NMI Natural and Medical Sciences Institute at the University of Tübingen, Markwiesenstrasse 55, 72770, Reutlingen, Germany.
Wagner TR; NMI Natural and Medical Sciences Institute at the University of Tübingen, Markwiesenstrasse 55, 72770, Reutlingen, Germany.
Kaiser PD; Pharmaceutical Biotechnology, Eberhard Karls University, Tübingen, Germany.
Traenkle B; NMI Natural and Medical Sciences Institute at the University of Tübingen, Markwiesenstrasse 55, 72770, Reutlingen, Germany.
Kienzle K; NMI Natural and Medical Sciences Institute at the University of Tübingen, Markwiesenstrasse 55, 72770, Reutlingen, Germany.
Bunk S; Department Internal Medicine I, University Hospital Tübingen, Otfried-Müller-Strasse 10, 72076, Tübingen, Germany.
Struemper C; Department Internal Medicine I, University Hospital Tübingen, Otfried-Müller-Strasse 10, 72076, Tübingen, Germany.
Haeberle H; Department Internal Medicine I, University Hospital Tübingen, Otfried-Müller-Strasse 10, 72076, Tübingen, Germany.
Schmauder K; Department of Anesthesiology and Intensive Care Medicine, University Hospital Tübingen, Tübingen, Germany.
Ruetalo N; Institute for Medical Microbiology and Hygiene, University Hospital Tübingen, Tübingen, Germany.
Malek N; German Center for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.
Althaus K; Institute for Medical Virology and Epidemiology, University Hospital Tübingen, Tübingen, Germany.
Koeppen M; Department Internal Medicine I, University Hospital Tübingen, Otfried-Müller-Strasse 10, 72076, Tübingen, Germany.
Rothbauer U; Center for Personalized Medicine, Eberhard Karls University, Tübingen, Germany.
Walz JS; Institute for Clinical and Experimental Transfusion Medicine, University Hospital Tübingen, Tübingen, Germany.
Schindler M; Department of Anesthesiology and Intensive Care Medicine, University Hospital Tübingen, Tübingen, Germany.
Bitzer M; NMI Natural and Medical Sciences Institute at the University of Tübingen, Markwiesenstrasse 55, 72770, Reutlingen, Germany.
Göpel S; Pharmaceutical Biotechnology, Eberhard Karls University, Tübingen, Germany.
Schneiderhan-Marra N; Department of Internal Medicine, Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital Tübingen, Tübingen, Germany.

Sci Rep ; 12(1): 7168, 2022 05 03.

Article de En | MEDLINE | ID: mdl-35505068

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: SARS-CoV-2 / COVID-19 Limites: Humans Langue: En Journal: Sci Rep Année: 2022 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google